Skip to main content

Advertisement

SpringerLink
Log in

Interstitial Cystitis and the Overlap With Overactive Bladder

  • Voiding Dysfunction and Lower Urinary Tract Symptoms (GH Badlani and HB Goldman, Section Editors)
  • Published:
Current Urology Reports Aims and scope Submit manuscript

Abstract

The overlap between interstitial cystitis–painful bladder syndrome and overactive bladder can present a diagnostic challenge to the treating practitioner. Both can present with similar patient symptoms. Further compounding this dilemma is the fact that no gold standard test exists to differentiate one from the other. This review will serve to highlight their similarities and distinguishing features.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: •• Of major importance

  1. Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Am J Obstet Gynecol. 2002;187:116–26.

    Article  PubMed  Google Scholar 

  2. Messing EM, Stamey TA. Interstitial cystitis: early diagnosis, pathology, and treatment. Urology. 1978;12:381–92.

    Article  PubMed  CAS  Google Scholar 

  3. Hanno P, Dmochowski R. Status of international consensus on interstitial cystitis/bladder pain syndrome/painful bladder syndrome: 2008 snapshot. Neurourol Urodyn. 2009;28:274–86.

    Article  PubMed  Google Scholar 

  4. Abrams P, Hanno P, Wein A. Overactive bladder and painful bladder syndrome: there need not be confusion. Neurourol Urodyn. 2005;24:149–50.

    Article  PubMed  Google Scholar 

  5. Payne C, Allee T. Goal achievement provides new insights into interstitial cystitis/painful bladder syndrome symptoms and outcomes. Neurourol Urodyn. 2009;28:13–7.

    Article  PubMed  Google Scholar 

  6. Diggs C, Meyer WA, Langenberg P, et al. Assessing urgency in interstitial cystitis/painful bladder syndrome. Urology. 2007;69:210–4.

    Article  PubMed  Google Scholar 

  7. Greenberg P, Brown J, Yates T, et al. Voiding urges perceived by patients with interstitial cystitis/painful bladder syndrome. Neurourol Urodyn. 2008;27:287–90.

    Article  PubMed  Google Scholar 

  8. Clemens JQ, Bogart LM, Liu K, et al. Perceptions of "urgency" in women with interstitial cystitis/bladder pain syndrome or overactive bladder. Neurourol Urodyn. 2011;30:402–5.

    Article  PubMed  Google Scholar 

  9. Propert KJ, Schaeffer AJ, Brensinger CM, et al. A prospective study of interstitial cystitis: results of longitudinal followup of the interstitial cystitis data base cohort. The Interstitial Cystitis Data Base Study Group. J Urol. 2000;163:1434–9.

    Article  PubMed  CAS  Google Scholar 

  10. Milsom I, Abrams P, Cardozo L, et al. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int. 2001;87:760–6.

    Article  PubMed  CAS  Google Scholar 

  11. Stewart WF, Van Rooyen JB, Cundiff GW, et al. Prevalence and burden of overactive bladder in the United States. World J Urol. 2003;20:327–36.

    PubMed  CAS  Google Scholar 

  12. Leppilahti M, Tammela TL, Huhtala H, Auvinen A. Prevalence of symptoms related to interstitial cystitis in women: a population based study in Finland. J Urol. 2002;168:139–43.

    Article  PubMed  Google Scholar 

  13. Rosenberg MT, Hazzard M. Prevalence of interstitial cystitis symptoms in women: a population based study in the primary care office. J Urol. 2005;174:2231–4.

    Article  PubMed  Google Scholar 

  14. Clemens JQ, Meenan RT, O'Keeffe, et al. Prevalence of interstitial cystitis symptoms in a managed care population. J Urol. 2005;174:576–80.

    Article  PubMed  Google Scholar 

  15. Lifford KL, Curhan GC. Prevalence of painful bladder syndrome in older women. Urology. 2009;73:494–8.

    Article  PubMed  Google Scholar 

  16. Inoue Y, Mita K, Kakehashi M, et al. Prevalence of painful bladder syndrome (PBS) symptoms in adult women in the general population in Japan. Neurourol Urodyn. 2009;28:214–8.

    Article  PubMed  Google Scholar 

  17. Clemens JQ, Meenan RT, Rosetti MC, Gao SY, Calhoun EA. Prevalence and incidence of interstitial cystitis in a managed care population. J Urol. 2005;173:98–102.

    Article  PubMed  Google Scholar 

  18. Berry SH, Elliott MN, Suttorp M, et al. Prevalence of symptoms of bladder pain syndrome/interstitial cystitis among adult females in the United States. J Urol. 2011;186:540–4.

    Article  PubMed  Google Scholar 

  19. •• Hanno P. Bladder pain syndrome (interstitial cystitis) and related disorders. In: Wein A, Kavoussi L, Novick A, Partin A, Peters C, editors. Campbell-Walsh Urology. 10th ed. Philadelpha: Elsevier-Saunders; 2011. p. 357–401. An excellent review of IC-BPS by a leader in the field.

    Google Scholar 

  20. Digesu GA, Khullar V, Cardozo L, Salvatore S. Overactive bladder symptoms: do we need urodynamics? Neurourol Urodyn. 2003;22:105–8.

    Article  PubMed  Google Scholar 

  21. Al-Ghazo MA, Ghalayini IF, Al-Azab R, et al. Urodynamic detrusor overactivity in patients with overactive bladder symptoms. Int Neurourol J. 2011;15:48–54.

    Article  PubMed  Google Scholar 

  22. Malone-Lee J, Henshaw DJ, Cummings K. Urodynamic verification of an overactive bladder is not a prerequisite for antimuscarinic treatment response. BJU Int. 2003;92:415–7.

    Article  PubMed  CAS  Google Scholar 

  23. Radley SC, Rosario DJ, Chapple CR, Farkas AG. Conventional and ambulatory urodynamic findings in women with symptoms suggestive of bladder overactivity. J Urol. 2001;166:2253–8.

    Article  PubMed  CAS  Google Scholar 

  24. Flisser AJ, Walmsley K, Blaivas JG. Urodynamic classification of patients with symptoms of overactive bladder. J Urol. 2003;169:529–33.

    Article  PubMed  Google Scholar 

  25. Kim SH, Kim TB, Kim SW, Oh SJ. Urodynamic findings of the painful bladder syndrome/interstitial cystitis: a comparison with idiopathic overactive bladder. J Urol. 2009;181:2550–4.

    Article  PubMed  Google Scholar 

  26. Kirkemo A, Peabody M, Diokno AC, et al. Associations among urodynamic findings and symptoms in women enrolled in the Interstitial Cystitis Data Base (ICDB) Study. Urology. 1997;49:76–80.

    Article  PubMed  CAS  Google Scholar 

  27. Irwin P, Samsudin A. Reinvestigation of patients with a diagnosis of interstitial cystitis: common things are sometimes common. J Urol. 2005;174:584–7.

    Article  PubMed  Google Scholar 

  28. Waxman JA, Sulak PJ, Kuehl TJ. Cystoscopic findings consistent with interstitial cystitis in normal women undergoing tubal ligation. J Urol. 1998;160:1663–7.

    Article  PubMed  CAS  Google Scholar 

  29. Foon R, Drake MJ. The overactive bladder. Ther Adv Urol. 2010;2:147–55.

    Article  PubMed  CAS  Google Scholar 

  30. •• Hanno PM, Burks DA, Clemens JQ, et al. AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome. J Urol. 2011;185:2162–70. A set of evidenced based guidelines in the evaluation treatment of IC-BPS.

    Article  PubMed  Google Scholar 

  31. Peters KM, Carrico DJ, Kalinowski SE, et al. Prevalence of pelvic floor dysfunction in patients with interstitial cystitis. Urology. 2007;70:16–8.

    Article  PubMed  Google Scholar 

  32. Hetrick DC, Ciol MA, Rothman I, et al. Musculoskeletal dysfunction in men with chronic pelvic pain syndrome type III: a case-control study. J Urol. 2003;170:828–31.

    Article  PubMed  Google Scholar 

  33. Berger RE, Ciol MA, Rothman I, Turner JA. Pelvic tenderness is not limited to the prostate in chronic prostatitis/chronic pelvic pain syndrome (CPPS) type IIIA and IIIB: comparison of men with and without CP/CPPS. BMC Urol. 2007;7:17.

    Article  PubMed  Google Scholar 

  34. Burgio KL, Locher JL, Goode PS, et al. Behavioral vs drug treatment for urge urinary incontinence in older women: a randomized controlled trial. JAMA. 1998;280:1995–2000.

    Article  PubMed  CAS  Google Scholar 

  35. Goode PS, Burgio KL, Locher JL, et al. Urodynamic changes associated with behavioral and drug treatment of urge incontinence in older women. J Am Geriatr Soc. 2002;50:808–16.

    Article  PubMed  Google Scholar 

  36. Weiss JM. Pelvic floor myofascial trigger points: manual therapy for interstitial cystitis and the urgency-frequency syndrome. J Urol. 2001;166:2226–31.

    Article  PubMed  CAS  Google Scholar 

  37. FitzGerald MP, Anderson RU, Potts J, et al. Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. J Urol. 2009;182:570–80.

    Article  PubMed  Google Scholar 

  38. Payne C, Fitzgerald MP, Burks D et al. Randomized multicenter clinical trial shows efficacy of myofascial physical therapy in women with interstitial cystitis/painful bladder syndrome (IC/PBS). J Urol. 2010, 183:Abstract #1035.

  39. Abrams P, Andersson KE. Muscarinic receptor antagonists for overactive bladder. BJU Int. 2007;100:987–1006.

    Article  PubMed  CAS  Google Scholar 

  40. Nabi G, Cody JD, Ellis G, et al. Anticholinergic drugs versus placebo for overactive bladder syndrome in adults. Cochrane Database Syst Rev. 2006;4:CD003781.

    PubMed  Google Scholar 

  41. Hanno P, Lin A, Nordling J, et al. Bladder pain syndrome. In: Abrams P, Cardozo L, Khoury S, Wein A, editors. Incontinence. 4th ed. Paris: Health Publication Ltd.; 2009. p. 1459–518.

    Google Scholar 

  42. Anger JT, Zabihi N, Clemens JQ, et al. Treatment choice, duration, and cost in patients with interstitial cystitis and painful bladder syndrome. Int Urogynecol J Pelvic Floor Dysfunct. 2011;22:395–400.

    Article  Google Scholar 

  43. Siddiqui NY, Wu JM, Amundsen CL. Efficacy and adverse events of sacral nerve stimulation for overactive bladder: a systematic review. Neurourol Urodyn. 2010;29:S18–23.

    Article  PubMed  Google Scholar 

  44. Chai TC, Zhang C, Warren JW, Keay S. Percutaneous sacral third nerve root neurostimulation improves symptoms and normalizes urinary HB-EGF levels and antiproliferative activity in patients with interstitial cystitis. Urology. 2000;55:643–6.

    Article  PubMed  CAS  Google Scholar 

  45. Maher CF, Carey MP, Dwyer PL, Schluter PL. Percutaneous sacral nerve root neuromodulation for intractable interstitial cystitis. J Urol. 2001;165:884–6.

    Article  PubMed  CAS  Google Scholar 

  46. Whitmore KE, Payne CK, Diokno AC, Lukban JC. Sacral neuromodulation in patients with interstitial cystitis: a multicenter clinical trial. Int Urogynecol J Pelvic Floor Dysfunct. 2003;14:305–8.

    Article  PubMed  Google Scholar 

  47. Comiter CV. Sacral neuromodulation for the symptomatic treatment of refractory interstitial cystitis: a prospective study. J Urol. 2003;169:1369–73.

    Article  PubMed  Google Scholar 

  48. Peters KM, Konstandt D. Sacral neuromodulation decreases narcotic requirements in refractory interstitial cystitis. BJU Int. 2004;93:777–9.

    Article  PubMed  CAS  Google Scholar 

  49. Powell CR, Kreder KJ. Long-term outcomes of urgency-frequency syndrome due to painful bladder syndrome treated with sacral neuromodulation and analysis of failures. J Urol. 2010;183:173–6.

    Article  PubMed  Google Scholar 

  50. Marinkovic SP, Gillen LM, Marinkovic CM. Minimum 6-year outcomes for interstitial cystitis treated with sacral neuromodulation. Int Urogynecol J Pelvic Floor Dysfunct. 2011;22:407–12.

    Article  Google Scholar 

  51. Ghazwani YQ, Elkelini MS, Hassouna MM. Efficacy of sacral neuromodulation in treatment of bladder pain syndrome: Long-term follow-up. Neurourol Urodyn. 2011 May 6. doi: 10.1002/nau.21037. [Epub ahead of print]

  52. Al-zahrani AA, Elzayat EA, Gajewski JB. Long-term outcome and surgical interventions after sacral neuromodulation implant for lower urinary tract symptoms: 14-year experience at 1 center. J Urol. 2011;185:981–6.

    Article  PubMed  Google Scholar 

  53. Zhao J, Nordling J. Posterior tibial nerve stimulation in patients with intractable interstitial cystitis. BJU Int. 2004;94:101–4.

    Article  PubMed  Google Scholar 

  54. Zhao J, Bai J, Zhou Y, Qi G, Du L. Posterior tibial nerve stimulation twice a week in patients with interstitial cystitis. Urology. 2008;71:1080–4.

    Article  PubMed  Google Scholar 

  55. Peters KM, Feber KM, Bennett RC. A prospective, single-blind, randomized crossover trial of sacral vs pudendal nerve stimulation for interstitial cystitis. BJU Int. 2007;100:835–9.

    Article  PubMed  Google Scholar 

  56. Schurch B, Schmid DM, Stöhrer M. Treatment of neurogenic incontinence with botulinum toxin A. N Engl J Med. 2000;342:665.

    Article  PubMed  CAS  Google Scholar 

  57. Brubaker L, Richter HE, Visco A, et al. Refractory idiopathic urge urinary incontinence and botulinum A injection. J Urol. 2008;180:217–22.

    Article  PubMed  Google Scholar 

  58. Flynn MK, Amundsen CL, Perevich M, et al. Outcome of a randomized, double-blind, placebo controlled trial of botulinum A toxin for refractory overactive bladder. J Urol. 2009;181:2608–15.

    Article  PubMed  CAS  Google Scholar 

  59. Sahai A, Khan MS, Dasgupta P. Efficacy of botulinum toxin-A for treating idiopathic detrusor overactivity: results from a single center, randomized, double-blind, placebo controlled trial. J Urol. 2007;177:2231–6.

    Article  PubMed  CAS  Google Scholar 

  60. Dowson C, Sahai A, Watkins J, et al. The safety and efficacy of botulinum toxin-A in the management of bladder oversensitivity: a randomised double-blind placebo-controlled trial. Int J Clin Pract. 2011;65:698–704.

    Article  PubMed  CAS  Google Scholar 

  61. Chapple CR, Dmochowski R, Nitti V, et al. Dose ranging Phase 2 study of BOTOX (onabotulinumtoxinA) in idiopathic OAB: benefit ⁄ risk assessment. Eur Urol Suppl. 2010;9:61.

    Google Scholar 

  62. Smith CP, Radziszewski P, Borkowski A, et al. Botulinum toxin a has antinociceptive effects in treating interstitial cystitis. Urology. 2004;64:871–5.

    Article  PubMed  Google Scholar 

  63. Giannantoni A, Costantini E, Di Stasi SM, et al. Botulinum A toxin intravesical injections in the treatment of painful bladder syndrome: a pilot study. Eur Urol. 2006;49:704–9.

    Article  PubMed  CAS  Google Scholar 

  64. Giannantoni A, Porena M, Costantini E, et al. Botulinum A toxin intravesical injection in patients with painful bladder syndrome: 1-year followup. J Urol. 2008;179:1031–4.

    Article  PubMed  CAS  Google Scholar 

  65. Kuo HC. Preliminary results of suburothelial injection of botulinum a toxin in the treatment of chronic interstitial cystitis. Urol Int. 2005;75:170–4.

    Article  PubMed  CAS  Google Scholar 

  66. Pinto R, Lopes T, Frias B, Silva A, et al. Trigonal injection of botulinum toxin A in patients with refractory bladder pain syndrome/interstitial cystitis. Eur Urol. 2010;58:360–5.

    Article  PubMed  CAS  Google Scholar 

  67. Kuo HC, Chancellor MB. Comparison of intravesical botulinum toxin type A injections plus hydrodistention with hydrodistention alone for the treatment of refractory interstitial cystitis/painful bladder syndrome. BJU Int. 2009;104:657–61.

    Article  PubMed  CAS  Google Scholar 

  68. Awad SA, Al-Zahrani HM, Gajewski JB, Bourque-Kehoe AA. Long-term results and complications of augmentation ileocystoplasty for idiopathic urge incontinence in women. Br J Urol. 1998;81:569–73.

    Article  PubMed  CAS  Google Scholar 

  69. Rössberger J, Fall M, Jonsson O, Peeker R. Long-term results of reconstructive surgery in patients with bladder pain syndrome/interstitial cystitis: subtyping is imperative. Urology. 2007;70:638–42.

    Article  PubMed  Google Scholar 

Download references

Disclosure

C.S. Elliot has nothing to disclose; C.K. Payne has received consultancy fees from Allergan Corp, Astellas Corp, and Afferent Pharmaceuticals and owns stocks with Curant, Inc.

Author information

Authors and Affiliations

  1. Department of Urology, Stanford University, Stanford, CA, USA

    Christopher S. Elliott & Christopher K. Payne

Authors
  1. Christopher S. Elliott
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christopher K. Payne
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christopher S. Elliott.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Elliott, C.S., Payne, C.K. Interstitial Cystitis and the Overlap With Overactive Bladder. Curr Urol Rep 13, 319–326 (2012). https://doi.org/10.1007/s11934-012-0264-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11934-012-0264-y

Keywords

Search

Navigation